Friday
SESSION 76: LATE BREAKING INFORMATION AND TRIAL STATUS RELATED TO CAROTID DISEASE AND ITS TREATMENT: CREST 2, ECST 2 AND ACST 2 STATUS AND ISSUES
SESSION 76 SCHEDULE
CREST 2 RELATED TOPICS
2:06 PM - 2:11 PM Where Do We Stand With CREST 2 And What Will It Tell Us
  Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM Will CREST 2 Incorporate Recent Advances In CAS (Cervical Access, Reversal Of Flow And Mesh Covered Stents) And What Will It Tell Us
  Presenter(s):L. Nelson Hopkins, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM CREST 2 May Change Little Or Nothing In Carotid Treatment Practice: Why Is This So
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
2:24 PM - 2:29 PM Why CREST 2 May Tell Us Very Little But Still Be Bad For Carotid Stenting (CAS)
  Presenter(s):Mark H. Wholey, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM Barriers To Enrollment In CREST 2: How Can They Be Overcome
  Presenter(s):Mark Conrad, MD, MMSc  
  View Slides in PDF      
2:36 PM - 2:41 PM History Of Transcervical CAS And How To Do It With Standard Equipment
  Presenter(s):Enrique Criado, MD, FACS  
  View Slides in PDF      
2:42 PM - 2:48 PM Panel Discussion
Moderator(s): L. Nelson Hopkins, MD / Max Amor, MD  
2:48 PM - 2:53 PM New Findings From CREST 1: Relationship Between Plaque Morphology And Post-Procedural Neurologic Events: Which Plaques Are High Risk For CAS But Not For CEA
  Presenter(s):Wesley S. Moore, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM Update On The ECST 2 Trial: What Is It Telling Us Relevant To Carotid Lesion Treatment
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD / Leo H. Bonati, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM Update On The ACST 2 Trial Comparing CAS And CEA In Asymptomatic Patients: Lessons Learned To Date
  Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS  
  View Slides in PDF      
3:06 PM - 3:11 PM Current Optimal Management Of Radiation Carotid Stenosis: Risk Of CEA And CAS And Which Is The Best Treatment For Symptomatic And Asymptomatic Disease In This Setting
  Presenter(s):Peter L. Faries, MD, FACS  
  View Slides in PDF      
3:12 PM - 3:17 PM International Variability In Carotid And AAA Treatment: Highlights From The International Consortium Of Vascular Registries
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
3:18 PM - 3:24 PM Panel Discussion
3:24 PM - 3:36 PM Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 76
previous next